Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Blueprint Genetics Oy
OY
Active
Y-tunnus 2230790-0
Keilaranta 14C, 02150
Espoo
Other human health activities n.e.c.
·
NACE 8699
Est. 2008 · 17 years old
224 employees
Share
Finland
/
Companies
/
Other human health activities n.e.c.
/
Blueprint Genetics Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
37M
28M
19M
9M
0M
2021: 23M
23M
2021
2022: 23M (0% vs 2021)
23M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
2025: 30M
30M
2025
EBITDA
EUR millions
6M
2M
-1M
-4M
-8M
2021: 3M
3M
2021
2022: -5M (-267% vs 2021)
-5M
-267%
2022
2023: 1M (+120% vs 2022)
1M
+120%
2023
2024: 3M (+200% vs 2023)
3M
+200%
2024
2025: 2M (-33% vs 2024)
2M
-33%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
30 067
0
0
22 804
22 936
Staff expenses
−17 361
−18 588
−18 258
−18 503
−13 927
EBITDA
2 358
3 169
1 184
−4 535
3 328
Depreciation & amort.
−1 077
−1 059
−1 260
−1 441
−1 863
EBIT
1 281
2 110
−76
−5 975
1 465
Net financials
−312
−15
−14
−9
115
Profit before tax
969
2 095
−90
−5 984
1 580
Tax
49
94
−47
45
128
Net profit
920
2 002
−42
−6 029
1 452
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
22 788
21 915
19 081
12 492
16 394
Equity
14 938
14 424
12 422
3 964
9 025
Long-term debt
0
0
0
—
—
Short-term debt
7 850
7 491
6 659
8 528
7 370
Total debt
7 850
7 491
6 659
8 528
7 370
Financial ratios
5-year trend
EBITDA margin
7,8 %
This company
15,8 %
Market median
This company
Market median
51% below market
2021
2025
Equity ratio
65,6 %
This company
38,2 %
Market median
This company
Market median
72% above market
2021
2025
Return on equity
6,2 %
This company
18,4 %
Market median
This company
Market median
66% below market
2021
2025
Net profit margin
3,1 %
This company
8,1 %
Market median
This company
Market median
62% below market
2021
2025
Asset turnover
1,32×
This company
1,12×
Market median
This company
Market median
18% above market
2021
2025
Debt / equity
0,53×
This company
0,62×
Market median
This company
Market median
15% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Blueprint Genetics Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
